Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net

Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers

(2016) Fabiola Puentes et al.   BRAIN PATHOLOGY

Emerging molecular biomarker targets for amyotrophic lateral sclerosis

(2016) Júlia Costa et al.   CLINICA CHIMICA ACTA

A2 Cryptic polyglutamine repeat sequence variation and somatic instability in huntington’s disease: drivers of pathology?

(2016) Darren Monckton et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS

(2016) Patrick Oeckl et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis

(2015) Patrick Weydt et al.   ANNALS OF NEUROLOGY

Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD

(2015) Emily Feneberg et al.   JOURNAL OF NEURAL TRANSMISSION

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

(2015) C.-H. Lu et al.   NEUROLOGY

Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation

(2014) A. Alberici et al.   NEUROLOGICAL SCIENCES

Progranulin protein levels are differently regulated in plasma and CSF

(2014) A. M. Nicholson et al.   NEUROLOGY

Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?

(2014) Laura Robelin et al.   Biomed Research International

Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases

(2013) Annemarie Hübers et al.   NEUROBIOLOGY OF AGING

Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature

(2013) A. Chiò et al.   NEUROEPIDEMIOLOGY

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

(2013) Johanna Gaiottino et al.   PLoS One

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS

(2012) Markus Otto et al.   Amyotrophic Lateral Sclerosis

Progranulin: An emerging target for FTLD therapies

(2012) Jennifer Gass et al.   BRAIN RESEARCH

Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology

(2011) Paul G. Ince et al.   ACTA NEUROPATHOLOGICA

S100B protein in neurodegenerative disorders

(2011) Johann Steiner et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis

(2011) Petra Steinacker et al.   PLoS One

Microglial Upregulation of Progranulin as a Marker of Motor Neuron Degeneration

(2010) Thomas Philips et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

(2010) S. D. Sussmuth et al.   NEUROLOGY

Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy

(2010) Angela S. Laird et al.   PLoS One

ALS and FTLD: two faces of TDP-43 proteinopathy

(2008) R. M. Liscic et al.   EUROPEAN JOURNAL OF NEUROLOGY

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration

(2008) R. Ghidoni et al.   NEUROLOGY

Progranulin genetic variability contributes to amyotrophic lateral sclerosis

(2008) K. Sleegers et al.   NEUROLOGY